TECELRA Q Code: Q2057

Drug & Product Overview

HCPCS Descriptor Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose

HCPCS Added Date April 1, 2025

Manufacturer Us Worldmeds

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Form Injection, Suspension

About TECELRA

Tecelra is a medication aligned to the HCPCS Q Code: Q2057 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by Us Worldmeds.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
83205-0001-02	Tecelra	USWM CT, LLC	1	Tecelra Intravenous In jection 10000000… Login for More

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

TECELRA Pricing & Reimbursement

Q2057 Private Payer Reimbursement

$770,620.00 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

TECELRA CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

TECELRA Medically Unlikely Edits (MUE)

The most billing units of Q2057 Medicare will pay for one patient in one day, as published by CMS. 1 unit = per therapeutic dose.

Practitioner Office & Hospital Outpatient

1 unit / day

Same limit in both settings

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

TECELRA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Unresectable or metastatic synovial sarcoma

Frequently Asked Questions

Is there a manufacturer-published TECELRA billing and coding guide?

Billing and coding information for TECELRA can be found through Adaptimmune. Visit Here →

What are the available TECELRA patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for TECELRA.

Where can I find TECELRA prescribing information?

TECELRA prescribing information can be found at the link below. Visit Here →

Where can I find TECELRA side effect information?

Side effect information for TECELRA can be found at the following source.

Does billing TECELRA require JZ/JW wastage modifiers?

CMS does not include TECELRA (Q2057) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q2057. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.